BIOMAT Database Logo BIOMAT Database Logo

Hydroxychloroquine in systemic lupus erythematosus. 1991

E Disla, and H Brar, and A Taranta

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006886 Hydroxychloroquine A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) Hydroxychlorochin,Oxychlorochin,Oxychloroquine,Hydroxychloroquine Sulfate,Hydroxychloroquine Sulfate (1:1) Salt,Plaquenil

Related Publications

E Disla, and H Brar, and A Taranta
Hydroxychloroquine in systemic lupus erythematosus.
April 2007, Lancet (London, England),
E Disla, and H Brar, and A Taranta
Hydroxychloroquine in systemic lupus erythematosus (SLE).
March 2017, Expert opinion on drug safety,
E Disla, and H Brar, and A Taranta
Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus.
August 2016, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
E Disla, and H Brar, and A Taranta
Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus.
December 2018, Indian journal of ophthalmology,
E Disla, and H Brar, and A Taranta
Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
October 1996, The Journal of rheumatology,
E Disla, and H Brar, and A Taranta
Hydroxychloroquine-Induced Reversible Hypomnesis in Systemic Lupus Erythematosus.
August 2018, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
E Disla, and H Brar, and A Taranta
Treatment of systemic lupus erythematosus: don't forget hydroxychloroquine.
October 2020, Annals of the rheumatic diseases,
E Disla, and H Brar, and A Taranta
Understanding Nonadherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus.
October 2019, The Journal of rheumatology,
E Disla, and H Brar, and A Taranta
[Application of hydroxychloroquine in children with systemic lupus erythematosus].
June 2019, Zhonghua er ke za zhi = Chinese journal of pediatrics,
E Disla, and H Brar, and A Taranta
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge.
January 2022, Therapeutic advances in musculoskeletal disease,
Copied contents to your clipboard!